11.2 Capital

11.2 Capital is an early-stage venture capital firm based in San Francisco, focusing on breakthrough technologies in artificial intelligence, augmented reality/virtual reality (AR/VR), robotics, space, and data-driven health. They have built a diverse portfolio that includes companies such as Bay Labs, Deep Genomics, and Hinge Health. Their investment strategy centers on early-stage technology startups with the potential for significant impact. 11.2 Capital has made 51 investments, with notable exits including Cruise Automation and Kindred AI. They emphasize supporting companies that leverage data at molecular and behavioral levels to innovate in healthcare, such as Apixio and Hindsait, which use data to enhance patient care and reduce costs. The firm is led by a team with deep expertise in technology and investment. Shelley Zhuang, a notable figure in the venture capital world, brings extensive knowledge in cybersecurity and AI. 11.2 Capital's approach involves not only providing capital but also strategic support to help startups scale effectively. Overall, 11.2 Capital is dedicated to fostering innovation in tech-driven sectors, providing both financial backing and strategic partnerships to enable startups to reach their full potential​.